Table of Contents 1 Market Overview 1.1 Hereditary Angioedema Drug Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Hereditary Angioedema Drug Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 C1 Esterase Inhibitor 1.2.3 Kallikrein Inhibitor 1.2.4 Selective Bradykinin B2 Receptor Antagonist 1.3 Market Analysis by Application 1.3.1 Overview: Global Hereditary Angioedema Drug Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Retail Pharmacies 1.3.3 Hospital Pharmacies 1.3.4 Online Pharmacies 1.4 Overview of Global Hereditary Angioedema Drug Market 1.4.1 Global Hereditary Angioedema Drug Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Pharming Group NV 2.1.1 Pharming Group NV Details 2.1.2 Pharming Group NV Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Pharming Group NV SWOT Analysis 2.1.4 Pharming Group NV Product and Services 2.1.5 Pharming Group NV Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 IBio Inc. 2.2.1 IBio Inc. Details 2.2.2 IBio Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 IBio Inc. SWOT Analysis 2.2.4 IBio Inc. Product and Services 2.2.5 IBio Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Takeda 2.3.1 Takeda Details 2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Takeda SWOT Analysis 2.3.4 Takeda Product and Services 2.3.5 Takeda Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 CSL Limited 2.4.1 CSL Limited Details 2.4.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 CSL Limited SWOT Analysis 2.4.4 CSL Limited Product and Services 2.4.5 CSL Limited Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Ionis Pharmaceuticals, Inc. 2.5.1 Ionis Pharmaceuticals, Inc. Details 2.5.2 Ionis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Ionis Pharmaceuticals, Inc. SWOT Analysis 2.5.4 Ionis Pharmaceuticals, Inc. Product and Services 2.5.5 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 BioCryst Pharmaceuticals, Inc. 2.6.1 BioCryst Pharmaceuticals, Inc. Details 2.6.2 BioCryst Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 BioCryst Pharmaceuticals, Inc. SWOT Analysis 2.6.4 BioCryst Pharmaceuticals, Inc. Product and Services 2.6.5 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Hereditary Angioedema Drug Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Hereditary Angioedema Drug Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Hereditary Angioedema Drug Manufacturer Market Share in 2019 3.3.2 Top 6 Hereditary Angioedema Drug Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Hereditary Angioedema Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Hereditary Angioedema Drug Sales and Market Share by Regions (2015-2020) 4.1.2 Global Hereditary Angioedema Drug Revenue and Market Share by Regions (2015-2020) 4.2 North America Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 4.3 Europe Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 4.5 South America Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Hereditary Angioedema Drug Sales, Revenue and Market Share by Country 5.1.1 North America Hereditary Angioedema Drug Sales and Market Share by Country (2015-2020) 5.1.2 North America Hereditary Angioedema Drug Revenue and Market Share by Country (2015-2020) 5.2 United States Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 5.3 Canada Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 5.4 Mexico Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Hereditary Angioedema Drug Sales, Revenue and Market Share by Country 6.1.1 Europe Hereditary Angioedema Drug Sales and Market Share by Country (2015-2020) 6.1.2 Europe Hereditary Angioedema Drug Revenue and Market Share by Country (2015-2020) 6.2 Germany Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 6.3 UK Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 6.4 France Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 6.5 Russia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 6.6 Italy Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Hereditary Angioedema Drug Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Hereditary Angioedema Drug Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Hereditary Angioedema Drug Revenue and Market Share by Regions (2015-2020) 7.2 China Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 7.3 Japan Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 7.4 Korea Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 7.5 India Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 7.7 Australia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Hereditary Angioedema Drug Sales, Revenue and Market Share by Country 8.1.1 South America Hereditary Angioedema Drug Sales and Market Share by Country (2015-2020) 8.1.2 South America Hereditary Angioedema Drug Revenue and Market Share by Country (2015-2020) 8.2 Brazil Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 8.3 Argentina Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Hereditary Angioedema Drug Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Hereditary Angioedema Drug Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Hereditary Angioedema Drug Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 9.3 Turkey Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 9.4 Egypt Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 9.5 South Africa Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Hereditary Angioedema Drug Sales and Market Share by Type (2015-2020) 10.2 Global Hereditary Angioedema Drug Revenue and Market Share by Type (2015-2020) 10.3 Global Hereditary Angioedema Drug Price by Type (2015-2020) 11 Global Hereditary Angioedema Drug Market Segment by Application 11.1 Global Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) 11.2 Global Hereditary Angioedema Drug Revenue Market Share by Application (2015-2020) 11.3 Global Hereditary Angioedema Drug Price by Application (2015-2020) 12 Market Forecast 12.1 Global Hereditary Angioedema Drug Sales, Revenue and Growth Rate (2021-2025) 12.2 Hereditary Angioedema Drug Market Forecast by Regions (2021-2025) 12.2.1 North America Hereditary Angioedema Drug Market Forecast (2021-2025) 12.2.2 Europe Hereditary Angioedema Drug Market Forecast (2021-2025) 12.2.3 Asia-Pacific Hereditary Angioedema Drug Market Forecast (2021-2025) 12.2.4 South America Hereditary Angioedema Drug Market Forecast (2021-2025) 12.2.5 Middle East & Africa Hereditary Angioedema Drug Market Forecast (2021-2025) 12.3 Hereditary Angioedema Drug Market Forecast by Type (2021-2025) 12.3.1 Global Hereditary Angioedema Drug Sales Forecast by Type (2021-2025) 12.3.2 Global Hereditary Angioedema Drug Market Share Forecast by Type (2021-2025) 12.4 Hereditary Angioedema Drug Market Forecast by Application (2021-2025) 12.4.1 Global Hereditary Angioedema Drug Sales Forecast by Application (2021-2025) 12.4.2 Global Hereditary Angioedema Drug Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Hereditary Angioedema Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Hereditary Angioedema Drug by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Hereditary Angioedema Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. Pharming Group NV Basic Information, Manufacturing Base and Competitors Table 8. Pharming Group NV Hereditary Angioedema Drug Major Business Table 9. Pharming Group NV Hereditary Angioedema Drug Total Revenue (USD Million) (2017-2018) Table 10. Pharming Group NV SWOT Analysis Table 11. Pharming Group NV Hereditary Angioedema Drug Product and Services Table 12. Pharming Group NV Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. IBio Inc. Basic Information, Manufacturing Base and Competitors Table 14. IBio Inc. Hereditary Angioedema Drug Major Business Table 15. IBio Inc. Hereditary Angioedema Drug Total Revenue (USD Million) (2017-2018) Table 16. IBio Inc. SWOT Analysis Table 17. IBio Inc. Hereditary Angioedema Drug Product and Services Table 18. IBio Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Takeda Basic Information, Manufacturing Base and Competitors Table 20. Takeda Hereditary Angioedema Drug Major Business Table 21. Takeda Hereditary Angioedema Drug Total Revenue (USD Million) (2017-2018) Table 22. Takeda SWOT Analysis Table 23. Takeda Hereditary Angioedema Drug Product and Services Table 24. Takeda Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. CSL Limited Basic Information, Manufacturing Base and Competitors Table 26. CSL Limited Hereditary Angioedema Drug Major Business Table 27. CSL Limited Hereditary Angioedema Drug Total Revenue (USD Million) (2017-2018) Table 28. CSL Limited SWOT Analysis Table 29. CSL Limited Hereditary Angioedema Drug Product and Services Table 30. CSL Limited Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table 32. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Major Business Table 33. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Total Revenue (USD Million) (2017-2018) Table 34. Ionis Pharmaceuticals, Inc. SWOT Analysis Table 35. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product and Services Table 36. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. BioCryst Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table 38. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Major Business Table 39. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Total Revenue (USD Million) (2017-2018) Table 40. BioCryst Pharmaceuticals, Inc. SWOT Analysis Table 41. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product and Services Table 42. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Global Hereditary Angioedema Drug Sales by Manufacturer (2018-2019) (K Units) Table 44. Global Hereditary Angioedema Drug Revenue by Manufacturer (2018-2019) (USD Million) Table 45. Global Hereditary Angioedema Drug Sales by Regions (2015-2020) (K Units) Table 46. Global Hereditary Angioedema Drug Sales Market Share by Regions (2015-2020) Table 47. Global Hereditary Angioedema Drug Revenue by Regions (2015-2020) (USD Million) Table 48. North America Hereditary Angioedema Drug Sales by Countries (2015-2020) (K Units) Table 49. North America Hereditary Angioedema Drug Sales Market Share by Countries (2015-2020) Table 50. North America Hereditary Angioedema Drug Revenue by Countries (2015-2020) (USD Million) Table 51. North America Hereditary Angioedema Drug Revenue Market Share by Countries (2015-2020) Table 52. Europe Hereditary Angioedema Drug Sales by Countries (2015-2020) (K Units) Table 53. Europe Hereditary Angioedema Drug Sales Market Share by Countries (2015-2020) Table 54. Europe Hereditary Angioedema Drug Revenue by Countries (2015-2020) (USD Million) Table 55. Asia-Pacific Hereditary Angioedema Drug Sales by Regions (2015-2020) (K Units) Table 56. Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Regions (2015-2020) Table 57. Asia-Pacific Hereditary Angioedema Drug Revenue by Regions (2015-2020) (USD Million) Table 58. South America Hereditary Angioedema Drug Sales by Countries (2015-2020) (K Units) Table 59. South America Hereditary Angioedema Drug Sales Market Share by Countries (2015-2020) Table 60. South America Hereditary Angioedema Drug Revenue by Countries (2015-2020) (USD Million) Table 61. South America Hereditary Angioedema Drug Revenue Market Share by Countries (2015-2020) Table 62. Middle East & Africa Hereditary Angioedema Drug Sales by Countries (2015-2020) (K Units) Table 63. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Countries (2015-2020) Table 64. Middle East & Africa Hereditary Angioedema Drug Revenue by Countries (2015-2020) (USD Million) Table 65. Middle East & Africa Hereditary Angioedema Drug Revenue Market Share by Countries (2015-2020) Table 66. Global Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 67. Global Hereditary Angioedema Drug Sales Share by Type (2015-2020) Table 68. Global Hereditary Angioedema Drug Revenue by Type (2015-2020) (USD Million) Table 69. Global Hereditary Angioedema Drug Revenue Share by Type (2015-2020) Table 70. Global Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 71. Global Hereditary Angioedema Drug Sales Share by Application (2015-2020) Table 72. Global Hereditary Angioedema Drug Sales Forecast by Regions (2021-2025) (K Units) Table 73. Global Hereditary Angioedema Drug Market Share Forecast by Regions (2021-2025) Table 74. Global Hereditary Angioedema Drug Sales Forecast by Type (2021-2025) (K Units) Table 75. Global Hereditary Angioedema Drug Market Share Forecast by Type (2021-2025) Table 76. Global Hereditary Angioedema Drug Sales Forecast by Application (2021-2025) Table 77. Global Hereditary Angioedema Drug Market Share Forecast by Application (2021-2025) Table 78. Direct Channel Pros & Cons Table 79. Indirect Channel Pros & Cons Table 80. Distributors/Traders/ Dealers List List of Figures Figure 1. Hereditary Angioedema Drug Picture Figure 2. Global Sales Market Share of Hereditary Angioedema Drug by Type in 2019 Figure 3. C1 Esterase Inhibitor Picture Figure 4. Kallikrein Inhibitor Picture Figure 5. Selective Bradykinin B2 Receptor Antagonist Picture Figure 6. Hereditary Angioedema Drug Sales Market Share by Application in 2018 Figure 7. Retail Pharmacies Picture Figure 8. Hospital Pharmacies Picture Figure 9. Online Pharmacies Picture Figure 10. Global Hereditary Angioedema Drug Market Status and Outlook (2015-2025) (USD Million) Figure 11. United States Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 12. Canada Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 13. Mexico Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 14. Germany Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 15. France Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 16. UK Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 17. Russia Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 18. Italy Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 19. China Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 20. Japan Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 21. Korea Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 22. India Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 23. Southeast Asia Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 24. Australia Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 25. Brazil Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 26. Egypt Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 27. Saudi Arabia Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 28. South Africa Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 29. Turkey Hereditary Angioedema Drug Revenue (Value) and Growth Rate (2015-2025) Figure 30. Global Hereditary Angioedema Drug Sales Market Share by Manufacturer in 2019 Figure 31. Global Hereditary Angioedema Drug Revenue Market Share by Manufacturer in 2019 Figure 32. Top 3 Hereditary Angioedema Drug Manufacturer (Revenue) Market Share in 2019 Figure 33. Top 6 Hereditary Angioedema Drug Manufacturer (Revenue) Market Share in 2019 Figure 34. Key Manufacturer Market Share Trend Figure 35. Global Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 36. Global Hereditary Angioedema Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 37. Global Hereditary Angioedema Drug Revenue Market Share by Regions (2015-2020) Figure 38. Global Hereditary Angioedema Drug Revenue Market Share by Regions in 2018 Figure 39. North America Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) Figure 40. Europe Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) Figure 41. Asia-Pacific Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) Figure 42. South America Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) Figure 43. Middle East & Africa Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) Figure 44. North America Hereditary Angioedema Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 45. North America Hereditary Angioedema Drug Sales Market Share by Countries (2015-2020) Figure 46. North America Hereditary Angioedema Drug Sales Market Share by Countries in 2018 Figure 47. North America Hereditary Angioedema Drug Revenue Market Share by Countries (2015-2020) (USD Million) Figure 48. North America Hereditary Angioedema Drug Revenue Market Share by Countries in 2018 Figure 49. United States Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 50. Canada Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 51. Mexico Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 52. Europe Hereditary Angioedema Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 53. Europe Hereditary Angioedema Drug Revenue Market Share by Countries (2015-2020) Figure 54. Europe Hereditary Angioedema Drug Revenue Market Share by Countries in 2019 Figure 55. Germany Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 56. UK Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 57. France Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 58. Russia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 59. Italy Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 60. Asia-Pacific Hereditary Angioedema Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 61. Asia-Pacific Hereditary Angioedema Drug Sales Market Share by Regions 2019 Figure 62. Asia-Pacific Hereditary Angioedema Drug Revenue Market Share by Regions 2019 Figure 63. China Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 64. Japan Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 65. Korea Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 66. India Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 67. Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 68. South America Hereditary Angioedema Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 69. South America Hereditary Angioedema Drug Sales Market Share by Countries in 2019 Figure 70. South America Hereditary Angioedema Drug Revenue Market Share by Countries in 2019 Figure 71. Brazil Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 72. Argentina Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 73. Middle East and Africa Hereditary Angioedema Drug Revenue and Growth Rate (2015-2020) (USD Million) Figure 74. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Countries in 2019 Figure 75. Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Countries (2015-2020) Figure 76. Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Countries in 2019 Figure 77. Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 78. Egypt Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 79. Turkey Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 80. South Africa Hereditary Angioedema Drug Sales and Growth Rate (2015-2020) (K Units) Figure 81. Global Hereditary Angioedema Drug Sales and Growth Rate (2021-2025) (K Units) Figure 82. Global Hereditary Angioedema Drug Revenue and Growth Rate (2021-2025) (USD Million) Figure 83. North America Sales Hereditary Angioedema Drug Market Forecast (2021-2025) (K Units) Figure 84. Europe Sales Hereditary Angioedema Drug Market Forecast (2021-2025) (K Units) Figure 85. Asia-Pacific Sales Hereditary Angioedema Drug Market Forecast (2021-2025) (K Units) Figure 86. South America Sales Hereditary Angioedema Drug Market Forecast (2021-2025) (K Units) Figure 87. Middle East & Africa Sales Hereditary Angioedema Drug Market Forecast (2021-2025) (K Units) Figure 88. Sales Channel: Direct Channel vs Indirect Channel

Pharming Group NV IBio Inc. Takeda CSL Limited Ionis Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc.